Moffitt Presentation Schedule 2024

We are excited to participate in the American Association for Cancer Research (AACR) Annual Meeting from April 5-10.

Moffitt Presentations at AACR 2024

Note - all times are listed as PST

Friday, April 5, 2024

Time	Location	Type	Title	Author/Presenter
3:01-3:21 p.m.	TBD	Educational	Evolutionary principles for optimizing cancer therapy and lessons learned in pilot trials	Robert Gatenby (Session Chairperson and Presenter)

Saturday, April 6, 2024

Time

Location

Type

Title

Author/Presenter

1:00 - 1:20 p.m. TBD Educational
Determinants of cysteine essentiality in cancer
Gina DeNicola

Sunday, April 7, 2024

Time	Location	Type	Title	Author/Presenter
1:30 - 1:50 p.m.	TBD	Major Symposium	“I felt so alone and isolated”: Opportunities to improve quality of life in young adult cancer survivors	Laura Oswald
1:30 - 5:00 p.m.	Section 3	Poster	71 / 7 - Differential infiltration of key immune cell populations across malignancies varying by immunogenic potential and likelihood of response to immunotherapy	Ahmad Tarhini
1:30 - 5:00 p.m.	Section 16	Poster	375 / 7 - Lipogenic phenotype is an adaptation to nutrient stress in the tumor microenvironment	Smitha Pillai
1:30 - 5:00 p.m.	Section 26	Poster	647 / 24 - FDA approved library screen revealed Ewing and clear cell sarcomas have increased sensitivity to filanesib over other cancer types	Hannah Walker-Mimms
1:30 - 5:00 p.m.	Section 36	Poster	876 / 20 - spatialGE: Empowering researchers to study the tumor microenvironment leveraging spatial transcriptomics	Oscar Ospina
1:30 - 5:00 p.m.	Section 37	Poster	908 / 23 - SeNMo: A self-normalizing deep learning model for enhanced multi-omics data analysis in oncology	Aakash Tripathi
1:30 - 5:00 p.m.	Section 46	Poster	1163 / 30 - Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironment	Alex Soupir
1:30 - 5:00 p.m.	Section 46	Poster	1143 / 10 - Dissection of melanoma and cutaneous lymphoma spatial molecular architecture by multimodal single-cell and spatial transcriptomics with generative AI	P. -L. Chen
3:50 - 4:05 p.m.	TBD	Mini Symposium	1217 - Defining the anti-tumor activity and immune effects of the RASMULTI(ON) inhibitor RMC-7977 in preclinical models of NRAS-mutant melanoma	L. A. D. Carvalho

Come rock out with The Checkpoints on Sunday night! Dr. Hwu and his fellow immunology bandmates from the Society for Immunotherapy of Cancer will be performing at the Manchester Grand Hyatt (1 Market Place, San Diego, CA, 92101) from 8:30-11:30 p.m.

Dr. Patrick Hwu with The Checkpoints Band

Monday, April 8, 2024

Time	Location	Type	Title	Author/Presenter
9:00 a.m. - 12:30 p.m.	Section 24	Poster	1924 / 2 - RTK signaling and WT RAS activity as vulnerabilities in tumors with acquired resistance to GDP-state selective KRASG12C inhibitors in preclinical models	Hitendra Solanki
9:00 a.m. - 12:30 p.m.	Section 33	Poster	2215 / 22 - Effects of a high-fiber, high-fruit and -vegetable, low-fat dietary intervention on rectal tissue bacteria	Doratha Byrd
9:00 a.m. - 12:30 p.m.	Section 34	Poster	2227 / 1 - Physical activity at breast cancer diagnosis and incident cardiovascular disease in the Pathways Study	A. R. Richards
9:00 a.m. - 12:30 p.m.	Section 44	Poster	2516 / 4 - Influence of pre-treatment nutrition and inflammation on immunotherapy response in non-small cell lung cancer	Lary Robinson
9:00 a.m. - 12:30 p.m.	Section 44	Poster	2529 / 17 - Comparison of small cell lung cancer transcriptional factor expression by immunohistochemistry, multiplex immunofluorescence, and a targeted RNA expression panel	Hilal Ozakinci
9:00 a.m. - 12:30 p.m.	Section 48	Poster	CT052 / 2 - A phase IB study of mRNA-based active cancer vaccine, BI1361849, combined with durvalumab and tremelimumab immunotherapy in patients with non-small cell lung cancer (NSCLC)	D. T. Chen
9:00 a.m. - 12:30 p.m.	Section 48	Poster	CT057 / 7 - Phase 1/2 trial of trametinib + ceritinib in patients with unresectable melanoma	Zeynep Eroglu
9:00 a.m. - 12:30 p.m.	Section 53	Late Breaking Poster	LB145 / 12 - Implementing timely germline genetic testing for patients with pancreatic cancer via a point-of-care digital education and health assessment tool	Jennifer Permuth
1:30 - 5:00 p.m.	Section 18	Poster	3041 / 11 - The small MAF transcription factor MAFG is a potent driver of melanoma	Florian Karreth
1:30 - 5:00 p.m.	Section 29	Poster	3368 / 25 - Combination of a chk1/2 dual inhibitor (prexasertib) and gemcitabine reveals a novel intrinsic synergy mechanism in head and neck squamous cell carcinoma	Vinayak Palve
1:30 - 5:00 p.m.	Section 33	Poster	3458 / 13 - DNA methylation-predicted blood protein levels and breast cancer risk	Brett Reid
1:30 - 5:00 p.m.	Section 34	Poster	3495 / 17 - Multi-omic landscape of squamous cell lung cancer	Isis Narvaez-Bandera
1:30 - 5:00 p.m.	Section 36	Poster	3557 / 17 - A pancancer gamma delta T cell repertoire atlas	Xiaoqing Yu
1:30 - 5:00 p.m.	Section 43	Poster	3734 / 20 - Tumoral and systemic immune modulation with neoadjuvant (NeoAd) intratumoral (IT) TAVO-EP (plasmid IL-12 electro gene transfer) and nivolumab (NIVO) in patients (pts) with operable locoregionally advanced melanoma	Ahmad Tarhini
2:35 - 2:50 p.m.	TBD	Mini Symposium	3886 - Analysis of clonal heterogeneity within paired primary and metastatic tumor samples of patients with solid tumors and implications for neoantigen-based personalized cancer vaccines	Alyssa Obermayer
2:35 - 2:50 p.m.	TBD	Mini Symposium	3928 - Genomic landscape and estimation of immune infiltration of soft tissue sarcoma histology subtypes from the ORIEN network	Alex Soupir
3:35 - 3:50 p.m.	TBD	Mini Symposium	3911 - A FGFR-p53 developmental signaling axis drives progression of salivary cancer	Julia Billington
3:35 - 3:50 p.m.	TBD	Mini Symposium	3918 - Targeting MARCO in combination with anti-CTLA4 leads to enhanced melanoma regression and immune cell infiltration via macrophage reprogramming	Hidenori Takahashi

Tuesday, April 9, 2024

Time	Location	Type	Title	Author/Presenter
9:00 a.m. - 12:30 p.m.	Section 17	Poster	4905 / 1 - Multimodal transformer model improves survival prediction in lung cancer compared to unimodal approaches	Aakash Tripathi
9:00 a.m. - 12:30 p.m.	Section 18	Poster	4406 / 10 - Single cell multiomic analysis reveals how genomic, epigenomic and transcriptomic events drive progression of multiple myeloma precursor states	Ariosto Siqueira Silva
9:00 a.m. - 12:30 p.m.	Section 33	Poster	4426 / 6 - Targeting MCT1 and PFKFB3 provokes synthetic lethality in small cell lung cancer	A. H. Prabhu
9:00 a.m. - 12:30 p.m.	Section 36	Poster	4824 / 13 - Multi-level intervention to increase minority cancer patient enrollment to clinical treatment trials- Study design considerations and baseline characteristics from the ACTWONDER2S Study	Dana Rollison
11:10 - 11:30 a.m.	TBD	Major Symposium	Serine metabolism in cancer	Gina DeNicola
1:30 - 5:00 p.m.	Section 11	Poster	5539 / 28 - PRDM16 is an intrinsic regulator of dormancy in bone disseminated prostate cancer cells	Mostafa Nasr
1:30 - 5:00 p.m.	Section 12	Poster	5571 / 27 - Collagen stabilization directs immune suppression in the head and neck squamous cell carcinoma hypoxic subtype	Sonal Srivastava
1:30 - 5:00 p.m.	Section 14	Poster	5608 / 6 - The BRCA1-associated role of CDK9 in response to DNA damage is independent of its canonical role in transcription	Thales C. Nepomuceno
1:30 - 5:00 p.m.	Section 37	Poster	6245 / 15 - Missed opportunity at the subcellular level: Enhancing the utility of cellular imaging modality in spatial transcriptomic profiling of tumor tissues	Xuefeng Wang
1:30 - 5:00 p.m.	Section 53	Late Breaking Poster	LB358 / 7 - Program and epigenetic control of stemness and exhaustion of tumor infiltrating CD8+ T lymphocytes	Dorina Avram
3:05 - 3:20 p.m.	TBD	Mini Symposium	6615 - Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testing	Alvaro Monteiro

Wednesday, April 10, 2024

Time	Location	Type	Title	Author/Presenter
9:00 a.m. - 12:30 p.m.	Section 4	Poster	7007 / 7 - 5hmc-sequencing identifies candidate genes in Puerto Rican Hispanic/Latino men with aggressive prostate cancer	M. S. Patel
9:00 a.m. - 12:30 p.m.	Section 6	Poster	7017 / 17 - Increased epigenetic age acceleration in young adult and early onset colorectal cancer patients post-treatment: A ColoCare Pilot Study
9:00 a.m. - 12:30 p.m.	Section 15	Poster	7325 / 7 - Integration of functional data to classify BRCA1/2 missense variants: An ENIGMA project	Alvaro Monteiro
9:00 a.m. - 12:30 p.m.	Section 15	Poster	7423 / 18 - BATCH-FLEX: Feature-level equalization of x-batch in heterogeneous cancer data	J. Davis
9:00 a.m. - 12:30 p.m.	Section 31	Poster	6742 / 11 - PV 10 induces endoplasmic reticulum stress and autophagy, triggering immunogenic cell death and anti-tumor immunity in head and neck squamous cell carcinoma	Sowjanya Thatikonda
9:00 a.m. - 12:30 p.m.	Section 35	Poster	6790 / 28 - Breaking barriers: A high-throughput 3D drug discovery platform for ovarian cancer	Greg Sawyer

Moffitt Presentation Schedule 2024

Moffitt Presentations at AACR 2024

Note - all times are listed as PST

Cambiar el idioma